LiveLive
SPX7628.9000-1.1600%IXIC26186.4100-1.2100%FTSE10697.5700-1.1500%GOLD4310.6000-0.1300%SILVER63.6200-0.2700%PLATINUM1776.00000.2800%PALLADIUM1307.0000-0.3800%BRENT106.06004.7900%DJI52421.2000-1.8600%WTI101.79005.9800%NDX29127.1600-1.4100%NATGAS2.88001.9100%BTC79358.00002.7000%RUT2892.2400-2.8000%VIX17.10008.7800%ETH2585.05003.1100%DAX25440.8100-2.1800%BNB730.61001.2900%XRP1.48009.4600%CAC408117.7800-2.4100%NKY63492.9900-2.7200%DOGE0.08000.7300%HSI24917.6000-1.9500%ADA0.21002.1700%NIFTY23398.1000-1.0000%SOL103.19002.3200%AAPL333.95004.3700%SENSEX74781.7600-1.0500%MSFT506.69001.4000%TASI10878.46000.1300%IBOV185373.27000.1200%GOOGL349.09003.1400%TSLA360.08001.6900%MERVAL3077979.80001.4300%TSX35691.3700-2.2500%USD/PKR277.04002.8800%ASX2008749.9000-2.9000%EUR/PKR320.09002.2200%STI5718.0200-1.2800%GBP/PKR374.1900-0.3400%SAR/PKR73.7600-0.1400%FBMKLCI1698.0100-0.9600%AED/PKR75.4200-0.0800%SET1591.0700-0.8400%KOSPI6684.3700-4.4500%USD/EUR0.86000.5800%TWSE45862.5200-2.6400%GASOLINE3.1400-2.2100%HEATOIL4.7500-1.0100%COPPER6.4000-5.8800%WHEAT722.00001.5100%CORN534.00005.1700%SOYBEANS1305.00000.7500%COFFEE289.2500-9.3800%COCOA6029.00001.7700%SUGAR19.06003.5900%COTTON85.04001.5600%TRX0.3400-0.2600%AVAX7.62002.8800%LINK11.73002.8200%DOT1.02000.2400%LTC53.8800-1.5800%SHIB0.00001.6700%TON1.3600-0.0600%XLM0.19007.9800%HBAR0.08002.5700%SUI0.74002.5100%APT0.6000-0.4800%UNI6.69007.1100%PEPE0.00003.4100%NEAR2.52008.6100%ARB0.14002.4200%OP0.10005.8900%MATIC0.13000.0000%INJ6.33004.2600%FIL0.9500-3.1800%ICP2.78000.5500%STX0.00000.0000%ETC7.66000.9300%ALGO0.10001.4200%VET0.01000.1400%THETA0.1900-4.0100%FTM0.0300-0.3500%SAND0.0400-0.0800%MANA0.0700-1.8000%AXS0.96000.6900%GALA0.00001.9700%CRV0.36001.8400%MKR1480.49002.1000%AMZN253.9700-1.7600%NVDA211.2100-8.3100%META666.18008.0100%NFLX80.30002.6100%AMD496.41003.9400%AVGO345.5100-3.4600%JPM350.3100-2.3200%V374.7700-0.0800%MA572.4200-1.1700%XOM164.33003.0500%CVX211.86001.5600%KO89.19001.2700%PEP136.5900-0.7600%DIS108.75003.2700%BA210.0200-1.0500%BABA109.3700-3.4200%JD27.3000-3.4000%PDD79.4500-3.3600%NIO3.6900-3.0300%SPY761.2500-1.1600%QQQ711.0600-1.1000%DIA524.8600-1.7300%IWM287.9600-2.7200%GLD392.7200-3.4500%SLV56.8500-4.9600%TLT81.0500-1.4100%HYG78.5800-0.7400%LQD104.3900-1.0300%XLF56.9000-2.0700%XLK184.2500-1.6200%XLE64.54000.7500%XLV167.7300-2.1700%SMH541.5000-4.5000%ARKK84.7600-1.6900%EEM65.9700-3.9700%IBIT44.7400-1.0800%QAR/PKR76.10000.2600%INR/PKR2.9000-0.7400%JPY/PKR1.79000.5200%CAD/PKR199.3100-0.9000%AUD/PKR197.8400-0.9900%NZD/PKR160.1100-1.8900%MYR/PKR67.9400-0.9200%THB/PKR8.3400-1.0300%EUR/USD1.1500-0.6800%GBP/USD1.3500-0.3000%USD/JPY154.40000.3500%USD/CHF0.82000.9800%AUD/USD0.7100-1.1100%USD/CAD1.39000.7100%NZD/USD0.5800-1.7000%USD/INR95.54001.1100%USD/CNY6.7100-0.0500%USD/HKD7.84000.0400%USD/SGD1.27000.4000%USD/KRW1345.80000.1700%USD/TRY48.62000.3500%USD/ZAR16.26001.7500%USD/MXN17.14001.1200%USD/BRL5.15000.4300%USD/RUB84.3900-1.8100%USD/NGN1317.1200-0.3000%USD/EGP51.79001.7700%USD/KES129.40000.7500%USD/BDT122.87003.1800%USD/LKR328.58003.1500%USD/IDR17630.0000-0.1900%USD/THB33.19001.0400%USD/MYR4.07000.7500%USD/PHP62.76000.4000%USD/VND25984.0000-0.1200%USD/ILS3.04001.0800%USD/SAR3.76003.0900%USD/AED3.67000.0300%USD/QAR3.64003.8600%USD/KWD0.3100-0.0300%USD/BHD0.38003.0900%USD/OMR0.39000.4700%SPX7628.9000-1.1600%IXIC26186.4100-1.2100%FTSE10697.5700-1.1500%GOLD4310.6000-0.1300%SILVER63.6200-0.2700%PLATINUM1776.00000.2800%PALLADIUM1307.0000-0.3800%BRENT106.06004.7900%DJI52421.2000-1.8600%WTI101.79005.9800%NDX29127.1600-1.4100%NATGAS2.88001.9100%BTC79358.00002.7000%RUT2892.2400-2.8000%VIX17.10008.7800%ETH2585.05003.1100%DAX25440.8100-2.1800%BNB730.61001.2900%XRP1.48009.4600%CAC408117.7800-2.4100%NKY63492.9900-2.7200%DOGE0.08000.7300%HSI24917.6000-1.9500%ADA0.21002.1700%NIFTY23398.1000-1.0000%SOL103.19002.3200%AAPL333.95004.3700%SENSEX74781.7600-1.0500%MSFT506.69001.4000%TASI10878.46000.1300%IBOV185373.27000.1200%GOOGL349.09003.1400%TSLA360.08001.6900%MERVAL3077979.80001.4300%TSX35691.3700-2.2500%USD/PKR277.04002.8800%ASX2008749.9000-2.9000%EUR/PKR320.09002.2200%STI5718.0200-1.2800%GBP/PKR374.1900-0.3400%SAR/PKR73.7600-0.1400%FBMKLCI1698.0100-0.9600%AED/PKR75.4200-0.0800%SET1591.0700-0.8400%KOSPI6684.3700-4.4500%USD/EUR0.86000.5800%TWSE45862.5200-2.6400%GASOLINE3.1400-2.2100%HEATOIL4.7500-1.0100%COPPER6.4000-5.8800%WHEAT722.00001.5100%CORN534.00005.1700%SOYBEANS1305.00000.7500%COFFEE289.2500-9.3800%COCOA6029.00001.7700%SUGAR19.06003.5900%COTTON85.04001.5600%TRX0.3400-0.2600%AVAX7.62002.8800%LINK11.73002.8200%DOT1.02000.2400%LTC53.8800-1.5800%SHIB0.00001.6700%TON1.3600-0.0600%XLM0.19007.9800%HBAR0.08002.5700%SUI0.74002.5100%APT0.6000-0.4800%UNI6.69007.1100%PEPE0.00003.4100%NEAR2.52008.6100%ARB0.14002.4200%OP0.10005.8900%MATIC0.13000.0000%INJ6.33004.2600%FIL0.9500-3.1800%ICP2.78000.5500%STX0.00000.0000%ETC7.66000.9300%ALGO0.10001.4200%VET0.01000.1400%THETA0.1900-4.0100%FTM0.0300-0.3500%SAND0.0400-0.0800%MANA0.0700-1.8000%AXS0.96000.6900%GALA0.00001.9700%CRV0.36001.8400%MKR1480.49002.1000%AMZN253.9700-1.7600%NVDA211.2100-8.3100%META666.18008.0100%NFLX80.30002.6100%AMD496.41003.9400%AVGO345.5100-3.4600%JPM350.3100-2.3200%V374.7700-0.0800%MA572.4200-1.1700%XOM164.33003.0500%CVX211.86001.5600%KO89.19001.2700%PEP136.5900-0.7600%DIS108.75003.2700%BA210.0200-1.0500%BABA109.3700-3.4200%JD27.3000-3.4000%PDD79.4500-3.3600%NIO3.6900-3.0300%SPY761.2500-1.1600%QQQ711.0600-1.1000%DIA524.8600-1.7300%IWM287.9600-2.7200%GLD392.7200-3.4500%SLV56.8500-4.9600%TLT81.0500-1.4100%HYG78.5800-0.7400%LQD104.3900-1.0300%XLF56.9000-2.0700%XLK184.2500-1.6200%XLE64.54000.7500%XLV167.7300-2.1700%SMH541.5000-4.5000%ARKK84.7600-1.6900%EEM65.9700-3.9700%IBIT44.7400-1.0800%QAR/PKR76.10000.2600%INR/PKR2.9000-0.7400%JPY/PKR1.79000.5200%CAD/PKR199.3100-0.9000%AUD/PKR197.8400-0.9900%NZD/PKR160.1100-1.8900%MYR/PKR67.9400-0.9200%THB/PKR8.3400-1.0300%EUR/USD1.1500-0.6800%GBP/USD1.3500-0.3000%USD/JPY154.40000.3500%USD/CHF0.82000.9800%AUD/USD0.7100-1.1100%USD/CAD1.39000.7100%NZD/USD0.5800-1.7000%USD/INR95.54001.1100%USD/CNY6.7100-0.0500%USD/HKD7.84000.0400%USD/SGD1.27000.4000%USD/KRW1345.80000.1700%USD/TRY48.62000.3500%USD/ZAR16.26001.7500%USD/MXN17.14001.1200%USD/BRL5.15000.4300%USD/RUB84.3900-1.8100%USD/NGN1317.1200-0.3000%USD/EGP51.79001.7700%USD/KES129.40000.7500%USD/BDT122.87003.1800%USD/LKR328.58003.1500%USD/IDR17630.0000-0.1900%USD/THB33.19001.0400%USD/MYR4.07000.7500%USD/PHP62.76000.4000%USD/VND25984.0000-0.1200%USD/ILS3.04001.0800%USD/SAR3.76003.0900%USD/AED3.67000.0300%USD/QAR3.64003.8600%USD/KWD0.3100-0.0300%USD/BHD0.38003.0900%USD/OMR0.39000.4700%
GuruAlpha
GuruAlpha

Idioma

Mahira Khan's Late Pregnancy Signals a Major Shift in South Asian Reproductive Health Trends
World

Mahira Khan's Late Pregnancy Signals a Major Shift in South Asian Reproductive Health Trends

Mahira Khan's high-profile pregnancy spotlighted late-stage motherhood, challenging deep-seated cultural stigmas and highlighting advanced reproductive care across South Asia.

GA

GuruAlpha News Desk

GuruAlpha News Desk

5 min read
ShareXFacebookWhatsApp

Mahira Khan's announcement of her pregnancy in her early 40s highlights the shifting demographics of motherhood across Pakistan and the South Asian diaspora. While clinical fertility declines after age 35 due to reduced oocyte quality and quantity, modern reproductive medicine, rigorous prenatal care, and lifestyle management enable millions of women to deliver healthy infants well into their late thirties and early forties.

When superstar Mahira Khan posted an Instagram picture draped in an ivory dress with hands cradling her visible baby bump, captioned simply with gratitude for 'Allah's plan,' she touched a nerve across the region. In a society where maternal health discussions remain shrouded in conservative rhetoric, her public embrace of late-in-life pregnancy brings an unspoken reality to light: South Asian women are increasingly postponing childbirth to pursue education, financial security, and career stability.

The Ovarian Clock: Demystifying Fertility After Age 35

In clinical obstetrics, pregnancy after age 35 has historically carried the label 'geriatric pregnancy' or 'advanced maternal age.' This distinction stems from well-documented biological shifts. A female child is born with roughly 1 to 2 million oocytes (eggs). By puberty, this number drops to approximately 300,000, and by age 37, the total count drops to around 25,000.

Beyond count, egg quality experiences a natural decline. Chromosomal non-disjunction—where cells fail to divide evenly—becomes more prevalent as women age. At age 25, the chance of a pregnancy involving chromosomal variations like Down syndrome (Trisomy 21) sits at roughly 1 in 1,250. By age 35, that ratio shifts to 1 in 350, and by age 40, it reaches approximately 1 in 100.

However, reproductive endocrinologists emphasize that decreased fertility does not equate to complete infertility. Anti-Müllerian Hormone (AMH) testing and baseline antral follicle counts now allow specialists to assess a woman's individual ovarian reserve accurately, replacing generic age benchmarks with personalized reproductive roadmaps.

Medical Innovations Transforming Advanced Maternal Age

The landscape of prenatal medicine has undergone a silent revolution over the past decade. Advanced diagnostic tools now mitigate many historic risks associated with pregnancies past age 35.

  • Non-Invasive Prenatal Testing (NIPT): Starting as early as the 10th week of gestation, a simple maternal blood draw isolates cell-free fetal DNA, identifying chromosomal conditions with over 99% accuracy without invasiveness.
  • Targeted Anomaly Scanning: High-resolution 3D and 4D ultrasound technologies permit fetal medicine specialists to observe cardiac structures and organ development with unprecedented detail at 18 to 22 weeks.
  • Proactive Metabolic Monitoring: Early screening for gestational diabetes mellitus (GDM) and preeclampsia allows for swift dietary interventions, low-dose aspirin therapy, and targeted monitoring, drastically reducing maternal-fetal morbidity.

Obstetric records across urban hubs like Karachi, Lahore, and Dubai show a steady rise in assisted reproductive technology (ART) uptake. Intrauterine insemination (IUI) and In-Vitro Fertilization (IVF) with Pre-implantation Genetic Testing for Aneuploidies (PGT-A) enable clinicians to select chromosomally balanced embryos before transfer, raising successful live birth rates significantly for women over 35.

Breaking Societal Stigma Across Pakistan and the Diaspora

For decades, South Asian cultural narratives framed motherhood as a time-sensitive duty best completed in early adulthood. Women past 30 who remained unmarried or childless faced immense familial pressure and social judgment.

The demographic reality, however, is rapidly evolving. Data from health networks in Pakistan indicates that urban women are marrying almost four years later on average compared to two decades ago. With women entering white-collar industries, journalism, law, and medicine in record numbers, delayed family planning has become a structural necessity rather than an isolated choice.

Mahira Khan’s open acknowledgment of her journey normalizes this transition. By reframing mature motherhood as a celebrated blessing rather than a source of panic, public figures help displace fear-driven medical myths with evidence-based healthcare practices. When mothers enter pregnancy with established emotional maturity, financial independence, and robust support networks, both parent and child reap quantifiable long-term benefits.

Clinical Protocols for Expectant Mothers Over 35

Obstetric consensus outlines clear, actionable steps for women planning a pregnancy past age 35:

  1. Pre-Conception Optimization: Administering high-dose folic acid (typically 400 to 800 mcg daily) three months before conception reduces neural tube defect risks substantially.
  2. Comprehensive Metabolic Profiling: Assessing thyroid function (TSH), lipid profiles, baseline blood pressure, and HbA1c prior to pregnancy ensures underlying conditions are stabilized before implantation.
  3. Consistent Prenatal Surveillance: Establishing a care plan with an experienced maternal-fetal medicine specialist ensures continuous monitoring of placental health and fetal growth velocities throughout all three trimesters.

Ultimately, while biological clocks remain a reality of human physiology, modern medicine and shifting cultural paradigms have rewritten what is achievable. Mature motherhood in South Asia is no longer a clinical anomaly—it is a thriving reality.

Frequently Asked Questions

What is the primary biological reason fertility declines after age 35?

Ovarian reserve and egg quality naturally decrease over time, increasing the likelihood of chromosomal variations during fertilization. However, proper medical screening and advanced diagnostic testing significantly lower risks during pregnancy.

What routine medical tests are recommended for pregnancies after 35?

Expectant mothers over 35 typically undergo Non-Invasive Prenatal Testing (NIPT), regular targeted anomaly ultrasounds, and frequent screenings for gestational diabetes and preeclampsia. These diagnostic tools help obstetricians manage potential complications early.

How does Mahira Khan's announcement impact cultural perceptions of motherhood in South Asia?

By publicly celebrating her pregnancy in her early 40s, Mahira Khan challenges long-standing South Asian societal stigmas around delayed childbirth. Her experience highlights a growing demographic trend of urban women prioritizing professional stability before expanding their families.

Source:bbc.com
Share this story
ShareXFacebookWhatsApp
GA

GuruAlpha News Desk

The GuruAlpha News team delivers accurate, timely coverage of breaking news, markets, technology, and lifestyle — in English and Urdu.

NewsBreaking

Related Stories

All World

More Stories

Home